SCHEMBL20645686

SCHEMBL20645686

COc1ccc(CN2CCCC(c3ccc(Br)cc3)C2)cc1

nearest known ligand 0.55

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.52
PDE2A O00408 3/20 0.50
HRH2 P25021 1/20 0.50
PTGIR P43119 1/20 0.49
HRH3 Q9Y5N1 1/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
SIGMAR1 Q99720 1/20 0.47
CHKA P35790 1/20 0.46
POLB P06746 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4485265 0.82 CNR2 (0.60) PDE2AMEN1KMT2A
SCHEMBL12125016 0.79 DRD2 (0.57)
SCHEMBL6360566 0.79 SIGMAR1 (0.63) HRH2MEN1KMT2ASIGMAR1
SCHEMBL8232974 0.78 HRH4 (0.60) KDM4EHRH2PTGIRHRH3KMT2A
SCHEMBL2291770 0.78 CNR2 (0.61)
SCHEMBL2298117 0.78 CNR2 (0.61)
SCHEMBL31629226 0.77 CXCR3 (0.44) KDM4EPDE2AHRH2MEN1KMT2A
SCHEMBL21342345 0.77 DRD2 (0.46) KDM4EPDE2AHRH2MEN1KMT2A
SCHEMBL30291085 0.77 ALDH1A1 (0.66) KDM4EHRH2PTGIRHRH3SIGMAR1
SCHEMBL4592208 0.77 LTA4H (0.50) KDM4EPDE2AHRH3MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109232575-B Pyrrole [1,2-b ] pyridazine compound or pharmaceutically acceptable salt thereof and application thereof 中国科学院上海药物研究所 2022-01-25 CN disclosed
CN-109232575-A Pyrroles's [1,2-b] pyridazine compound or its officinal salt and their purposes 中国科学院上海药物研究所 2019-01-18 CN disclosed
WO-2019011217-A1 PYRROLO[1,2-B]PYRIDAZINE COMPOUNDS OR PHARMACOLOGICALLY ACCEPTABLE SALTS THEREOF AND USE THEREOF 中国科学院上海药物研究所 2019-01-17 WO disclosed